MDSCs also produce interleukin-10 (IL-10) and transforming growth factor β 1 (TGFβ-1) that inhibit functions of immune effector cells [1,2,3,13,17], increase expression of programmed death-ligand 1 (PD-L1) [1,2,3,18] which can downregulate anti-tumor T cell-functions by interacting with PD-1 receptor expressed on T cells [19], secrete angiogenic factors like VEGF [20,21], and growth factors, matrix metalloproteinases, and cytokines promoting tumor growth and activation of regulatory T cells (Tregs) [2,22,23]. The gene discussed is TGFB1; the disease is neoplasm.